IRIS
MAIDA, Ivana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.662
NA - Nord America 3.658
AS - Asia 1.323
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 11
AF - Africa 7
Totale 8.688
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.639
IT - Italia 1.276
UA - Ucraina 920
CN - Cina 878
FR - Francia 417
DE - Germania 343
SG - Singapore 268
SE - Svezia 259
FI - Finlandia 142
IE - Irlanda 96
GB - Regno Unito 73
HK - Hong Kong 67
CZ - Repubblica Ceca 38
KR - Corea 32
BE - Belgio 23
CA - Canada 18
IR - Iran 18
IN - India 17
PL - Polonia 17
AU - Australia 15
RU - Federazione Russa 14
TR - Turchia 14
EU - Europa 11
CH - Svizzera 9
NL - Olanda 8
JP - Giappone 6
HU - Ungheria 5
BG - Bulgaria 4
IL - Israele 4
VN - Vietnam 4
BR - Brasile 3
RO - Romania 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CL - Cile 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AT - Austria 1
BY - Bielorussia 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
HR - Croazia 1
ID - Indonesia 1
IQ - Iraq 1
IS - Islanda 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UG - Uganda 1
VE - Venezuela 1
Totale 8.688
Salva come PNG Salva come JPEG
Città #
Chandler 913
Jacksonville 556
Princeton 332
Nanjing 252
Singapore 207
Dearborn 187
Wilmington 124
New York 107
Nanchang 103
Boardman 99
Sassari 98
Ann Arbor 97
Dublin 96
Rome 92
Shenyang 73
Beijing 70
Milan 69
Hong Kong 62
Woodbridge 50
Hebei 48
Changsha 45
Tianjin 44
Santa Clara 40
Andover 37
Brno 37
Jiaxing 36
Naples 35
Jinan 34
Seoul 30
Ningbo 27
Hangzhou 26
Zhengzhou 25
Ashburn 24
Norwalk 24
Brussels 23
Munich 23
Turin 23
Kunming 22
Florence 21
Helsinki 21
Bologna 17
Toronto 16
Ardabil 15
San Francisco 15
San Mateo 15
Leawood 14
Dallas 12
Guangzhou 12
Taizhou 12
Bari 10
Mountain View 10
Verona 10
Auburn Hills 9
Brescia 9
Izmir 9
Monmouth Junction 9
Augusta 8
Lanzhou 8
Genoa 7
Palermo 7
Washington 7
Catania 6
Napoli 6
Ravenna 6
Shanghai 6
Amsterdam 5
Budapest 5
Changchun 5
Cosenza 5
Huskvarna 5
Pisa 5
Sydney 5
Tokyo 5
Cagliari 4
Cernusco sul Naviglio 4
Hanoi 4
Hefei 4
Iesi 4
London 4
Los Angeles 4
Monza 4
Novara 4
Nuremberg 4
Padova 4
Salzano 4
Venice 4
Canberra 3
Cergy 3
Corridonia 3
Frankfurt am Main 3
Fuzhou 3
Genova 3
Haifa 3
Hanover 3
Lugano 3
Massarosa 3
Melbourne 3
Modena 3
Mumbai 3
Noicattaro 3
Totale 4.621
Salva come PNG Salva come JPEG
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 1.200
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 95
Aspetti epidemiologici sulla colonizzazione da Streptococcus agalactiae nelle donne in gravidanza. 84
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 82
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 77
Antibiotic resistant H-pylori are extremely common in Sardinia. 73
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 71
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 70
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 70
Approccio molecolare nello studio di un episodio infettivo ospedaliero da Pseudomonas aeruginosa 68
Utilizzo della metodologia bayesiana per lo studio della variazione geografica del rischio in epidemiologia. 68
Listeria monocytogenes meningoencephalitis: molecular methods for diagnosis and for monitoring the response to chemotherapy 67
Approccio molecolare nella diagnosi della tubercolosi umana 66
Accertamento diagnostico di meningoencefalite da Listeria monocytogenes mediante PCR in soggetti immunocompetenti 66
Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. 66
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C 66
Strategie di sorveglianza attiva e networking per il controllo delle infezioni da L. monocytogenes 65
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 62
OPERA: use of pegylated interferon plus ribavirin for treating hepatitis C/HIV co-infection in interferon-naive patients. 62
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 61
Analisi del case-mix ospedaliero. Il controllo dei ricoveri outlier 61
Andamento delle infezioni nosocomiali nel complesso chirurgico Università- Azienda USL n. 1- Sassari. 61
Surveillance of Poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results 61
HIV related aneurisms 61
Andamento della parotite epidemica nell’Azienda USL n.1 di Sassari e considerazioni sulle strategie vaccinali 60
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies 59
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 59
Valutazione della qualità delle schede di dimissione ospedaliera 59
Associazione sierologia tra HIV e Trichomonas vaginalis nella popolazione femminile del Nord-Sardegna. 58
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir. 58
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome 57
Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains 56
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome 56
Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center 56
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 56
Analisi dell'attività dei C.I.O. in ambito regionale e proposta di un modello organizzativo - funzionale 56
Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma 56
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 56
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes 56
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies 55
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study. 55
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 55
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 55
Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial 55
Lysteria monocytogenes meningoencephalitis: molecular methods for diagnosis and for monitoring the response to chemotherapy 55
Aspetti epidemiologici di infezioni gastroenteriche in paesi in via di sviluppo 55
Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir 54
Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients 53
New paradigms in the management of HIV and hepatitis C virus coinfection 53
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience 53
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 53
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus 53
Clonal relationships among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting 52
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 52
QuantiFERON TB Gold: a new method for latent tuberculosis infection 52
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 52
alpha-and gamma-tocophetol modulate the apoptotic signaling induced by oxidized low-density lipoprotein in human coronaric smooth muscle cells 52
Triple-nucleoside regimens versus efavirenz 50
HIV-related aneurysms 50
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. 50
Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring 50
Clonal relations among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting 49
Correlates of HIV, HBV, and HCV infection in a prison inmate population: Results from a multicentre study in Italy 49
Hepatitis C virus-RNAclearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin 49
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients 48
Monitoraggio di metalli pesanti nelle acque costiere della Sardegna settentrionale mediante utilizzo di indicatori biologici 48
Impiego degli antibiotici in un DRG chirurgico specialistico e verifica dei costi 48
Rapid detection and identification of Mycobacterium tuberculosis by Real Time PCR and Bactec 960 MIGT 48
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 48
Serum homocysteine levels are increased in women with gestational diabetes mellitus 48
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 48
Inquinamento ambientale nelle sale operatorie. Nota II: condizioni microclimatiche e microbiologiche 48
Severe liver disease associated with prolonged exposure to antiretroviral drugs 48
Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B 47
Upper Gastrointestinal Bleeding May Unmask Didanosine-Associated Portal Hepatopathy in HIV/HCV Co-infected Patients 46
Liver Fibrosis Stage and HCV Genotype Distribution in HIV-HCV Coinfected Patients with Persistently Normal Transaminases 46
Database per il monitoraggio del rischio professionale negli operatori sanitari 46
Unexplained severe portal hypertension in HIV-infected patients: a new clinical entity? 46
Database per il monitoraggio del rischio professionale negli operatori sanitari 46
Does counselling increase sustained benefit of HAART among prison inmates after release to the community? 45
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 45
Liver transplantation in HIV-HCV coinfected candidates: What is the most appropriate time for evaluation? 45
Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapies 45
MOLECULAR APPROACH IN THE DIAGNOSIS OF HUMAN TUBERCULOSIS 45
Complications in treating chronic hepatitis B in patients with HIV 45
Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b 45
Non cirrhotic portal hypertension in HIV-infected patients 44
PREVENTION OF TRAVEL ASSOCIATED INFECTION DUE TO LEGIONELLA: MICROBIOLOGIC ANALYSIS IN LINERS AND CRUISE SHIPS 44
Severe liver disease of unknown origin in HIV-infected patients 43
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 43
HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART 43
Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity 43
Severe portal hypertension not associated to cirrhosis in HIV+ patients 42
Rickettsia monacensis as Cause of Mediterranean Spotted Fever-like Illness, Italy 42
Modulation by α- and γ-tochopherol and oxidized low density lipoprotein in human coronaric smooth muscle cells 42
Liver Enzyme Elevation in Hepatitis C Virus (HCV)-HIV-Coinfected Patients Prior and After Initiating HAART: Role of HCV genotypes 41
Il personale infermieristico del Complesso Università-Ospedale di Sassari. Nota 2: Indagine sullo stato vaccinale 41
HIV associated hepatopathy – a new clinical condition: prevalence, etiology and outcome 41
Severe portal hypertension in HIV patients with no primary liver disease: prevalence, histology and potential etiology 41
Prevention of travel associated infection due to Legionella: microbiologic analysis in liners and cruise ships 41
Totale 6.567
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.171
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.346 0 0 143 20 155 163 290 70 187 141 163 14
2020/20211.485 165 9 212 15 155 82 164 16 244 230 138 55
2021/2022965 152 27 24 46 18 19 45 67 77 32 110 348
2022/20231.962 199 101 39 314 190 334 21 222 331 25 108 78
2023/2024930 105 62 32 41 193 96 27 52 16 57 97 152
2024/2025546 113 161 272 0 0 0 0 0 0 0 0 0
Totale 8.990